In conclusion, our findings suggest that MPP, a novel synthetic derivative of chalcone, alone or in combination with curcumin, could serve as an effective anti-inflammatory and cytotoxic treatment for combating breast and ovarian cancer, mediated by the inhibitory effect of this combination on NF-κB activity and its downstream genes. Here, NFKB1 is linked to ovarian cancer.